TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
XOMA

XOMA Royalty Corporation

Healthcare · Biotechnology

40.20$ +0.0% vs. previous close Closing price · As of: Jul 21, 2026

Statements

Income Statement

XOMA Royalty Corporation (XOMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 52 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement XOMA
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
3.6 18 6.3 2.4 6.7 17 30 24 3.7 19 29 84 68 98 34 58 34 35 19 55 5.6 53 5.3 18 29 38 6.0 4.8 28 52
-2.1 -2.0 -1.6 -1.2 1.9 43 60 29 16 12 15 17 17 9.1 14 38 0.1 27 29 21 1.4 7.9 1.7 1.3 0.2 0.2 0.3 0.1 0.2 3.0
5.7 20 7.9 3.6 4.8 17 30 24 -13 19 29 84 68 98 34 58 34 8.1 -11 35 4.2 45 3.6 17 29 38 5.8 4.6 28 49
26 30 44 42 30 36 43 57 50 40 52 66 83 58 77 68 68 75 81 71 44 7.9 1.7 1.3 0.2 0.2 0.2 0.1 2.9 1.7
5.5 5.6 5.4 6.1 6.1 8.7 19 24 32 15 18 21 24 24 23 24 17 18 20 21 18 24 19 21 17 20 23 26 34 36
34 38 51 49 34 45 62 82 82 55 70 87 107 82 101 92 85 93 101 91 63 32 20 21 17 20 23 46 68 38
-28 -17 -43 -45 -29 -27 -32 -58 -78 -36 -41 -2.5 -39 13 -67 -34 -57 -58 -82 -40 -62 17 -17 -3.9 12 18 -17 -42 -40 11
0.0 0.0 0.0 0.0 2.7 0.0 0.0 1.9 1.2 4.3 13 12 7.0 4.9 0.4 2.5 4.3 4.6 4.3 4.2 3.9 1.2 0.9 1.9 1.8 0.5 0.3 0.6 14 13
-29 -16 -49 -44 -27 -25 -31 -59 -79 2.8 -52 -12 -46 6.3 -69 -33 -71 -124 -38 -21 -54 16 -13 -2.0 12 16 -17 -41 -19 32
0.8 -1.3 4.3 0.6 0.0 0.7 1.2 1.1 0.8 0.0 11 9.8 -0.4 5.7 0.0 0.0 -0.1 0.0 4.2 4.2 4.7 1.7 -0.1 5.7 -1.5 0.1 0.0 0.7 -5.7 0.1
-29 -16 -47 -46 -29 -28 -33 -59 -79 2.8 -52 -12 -45 0.6 -69 -33 -71 -124 -38 -21 -54 15 -13 -2.0 13 16 -17 -41 -14 32
-26 -15 -41 -44 -31 -26 -30 -54 -73 -36 -35 4.2 -32 18 -63 -25 -63 -117 -32 -15 -49 21 -12 -3.9 14 17 -17 -23 -5.4 48

Data as of: July 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?